Diffuse alveolar hemorrhage

Progress in Respiratory Research

Volumn 36, Issue , 2007, Pages 250-263

  Olson, A ^a   Schwarz, M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49449092270     PISSN: 14222140     EISSN: 16623932     Source Type: Book Series    
DOI: 10.1159/000102695     Document Type: Review

References (125)

1. Travis WD, Colby TV, Lombard C, Carpenter HA: A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14:1112-1115.
2. Spencer H: Pulmonary lesions in polyarteritis nodosa. Br J Tuberc Dis Chest 1957;51:123-130.
3. Mark EJ, Ramirez JF: Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985;109:413-418.
4. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS: Surgical pathology of the lung in Wegener's granulomatosis. Am J Surg Pathol 1991;15:315-333.
5. Hyatt RW, Adelstein ER, Halazun JF, Lukens JN: Ultrastructure of the lung in idiopathic pulmonary hemosiderosis. Am J Med 1972;52:822-829.
6. Leatherman JW, Davies SF, Hoidal JR: Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) 1984;63:343-361.
7. Lombard CM, Colby TV, Elliott CG: Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome. Hum Pathol 1989;20:445-451.
8. Travis WD, Koss MN, Ferrans VJ: The lung in connective tissue disorders; in Haselton PS (ed): Spencer's Pathology of the Lung. New York, McGraw-Hill, 1996, pp 803-834.
9. Zamora MR, Warner ML, Tuder R, Schwarz MI: Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997;76:192-202.
10. Fontenot AP, Schwarz MI: Diffuse alveolar hemorrhage; in Schwarz MI, King TE (eds): Interstitial Lung Disease. Ontario, BC Decker, 2003, pp 632-656.
11. Collard HR, Schwarz MI: Diffuse alveolar hemorrhage. Clin Chest Med 2004;25:583-592.
12. Woolley K, Stark P: Pulmonary parenchymal manifestations of mitral valve disease. Radiographics 1999;19:965-972.
13. Lynch DA, Brown KK, Lee JS, Hale VAE: Imaging of diffuse infiltrative lung disease; in Lynch DA, Newell JD, Lee JS (eds): Imaging of Diffuse Lung Disease. Hamilton, Ontario, BC Decker, 2000, pp 57-40.
14. Rubin GD, Edwards DK 3rd, Reicher MA, Doemeny JM, Carson SH: Diagnosis of pulmonary hemosiderosis by MR imaging. AJR Am J Roentgenol 1989;152:573-574.
15. Greening AP, Hughes JM: Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage. Clin Sci 1981;60:507-512.
16. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE: Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 1990;65:847-856.
17. Gross WL, Schmitt WH, Csernok E: ANCA and associated disease: immunodiagnostic and pathogenic aspects. Clin Exp Immunol 1993;91: 1-12.
18. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS: Surgical pathology of the lung in Wegener's granulomatosis: review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991;15:315-333.
19. Yoshikawa Y, Watanabe T: Pulmonary lesions in Wegener's granulomatosis: a clinicopathologic study of 22 autopsy cases. Hum Path 1986;17:401-410.
20. Niles J, Bottinger E, Saurina GR, Kelly KJ, Pan G, Collins BA, McCluskey RT: The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996;156:440-445.
21. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B: Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-430.
22. Bosch X: Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis. Ann Rheum Dis 1999;58:644-647.
23. Specks U: Pulmonary vasculitis; in Schwarz MI, King TE (eds): Interstitial Lung Disease. Ontario, BC Decker, 2003, pp 632-656.
24. Schwarz MI, Brown KK: Small vessel vasculitis of the lung. Thorax 2000;55:502-510.
25. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JWC, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen C, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44.
26. De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Lugmani R, Jayne DR: Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:2461-2469.
27. Jayne DRW, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, Lockwood CM: Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Q J Med 2000;93:433-439.
28. Lauque D, Candranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier JF: Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires (GERM'O'P). Microscopic polyangiitis with alveolar hemorrhage: a study of 29 cases and review of the literature. Medicine (Baltimore) 2000;79:222-233.
29. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 1985;56:467-483.
30. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, Noel LH, Trepo C: Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995;74:238-253.
31. Betensley AD, Yankaskas JR: Factor VIIa for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med 2002;166:1291-1292.
32. Schwarz MI, Mortenson RL, Colby TV, Waldron JA, Lynch DA, Hutt MP, Cherniack RM, King TE: Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation. Am Rev Resp Dis 1993;148:507-511.
33. Eschun GM, Mink SN, Sharma S: Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 2003;123:297-301.
34. Bosch X, Font J, Mirapeix E, Revert L, Ingelmo M, Urbano-Marquez A: Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis. Am Rev Respir Dis 1992;146:1326-1329.
35. Bosch X, Lopez-Soto A, Mirapeix E, Font J, Ingelmo M, Urbano-Marquez A: Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 1994;118:517-522.
36. Jennings CA, King TE Jr, Tuder R, Cherniack RM, Schwarz MI: Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med 1997;155:1101-1109.
37. Zamora MR, Warner ML, Tuder R, Schwarz MI: Diffuse alveolar hemorrhage and systemic lupus erythematosus. Medicine (Baltimore) 1997;76:192-202.
38. Eagan JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ: Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978;57:545-560.
39. Myers JL, Katzenstein AA: Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85:552-556.
40. Matthay RA, Schwarz MI, Petty TL, Stanford RE, Gupta RC, Sahn SA, Steigerwald JC: Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975;54:397-409.
41. Howe HS, Boey ML, Fong KY, Feng PH: Pulmonary hemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann Rheum Dis 1988;47:869-872.
42. Carette S, Macher AM, Nussbaum A, Plotz PH: Severe, acute pulmonary disease in patients with SLE: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum 1984;14:52-59.
43. Nguyen VA, Gotwald T, Prior C, Obermoser G, Sepp N: Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus. Lupus 2005;14:557-560.
44. Zamora MR, Warner ML, Tuder R, Schwarz MI: Diffuse alveolar hemorrhage and systemic lupus erythematosus. Medicine (Baltimore) 1997;76:192-202.
45. Santos-Ocampo AS, Mandell BF, Fessler BJ: Alveolar hemorrhage in systemic lupus erythematosus. Chest 2000;118:1083-1090.
46. Schwarz MI, Zamora MR, Hodges TN, Chan ED, Bowler RP, Tuder RM: Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998;113:1609-1615.
47. Schwarz MI, Sutarik JM, Nick JA, Leff JA, Emlen JW, Tuder RM: Pulmonary capillaritis and diffuse alveolar hemorrhage: a primary manifestation of polymyositis. Am J Respir Crit Care Med 1995;151:2037-2040.
48. Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, Gur H: Pulmonary-renal syndrome in systemic sclerosis. Semin Arthritis Rheum 2001;30:403-410.
49. Gertner E: Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol 1999;26:805-807.
50. Chajek T, Fainaru M: Behcet's disease: report of 41 cases and a review of the literature. Medicine (Baltimore) 1975;54:179-196.
51. Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S: Renal Behçet's disease: a cumulative analysis. Semin Arthritis Rheum 2002;31:317-337.
52. Raz I, Okon E, Chajek-Saul T: Pulmonary manifestations in Behcet's syndrome. Chest 1989;95:585-589.
53. Gamble CN, Wiesner KB, Shapiro RF, Boyer WJ: The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behcet's disease. Am J Med 1979;66:1031-1039.
54. Abdallah MA, Ragab N, Khalil R, Kamel N: Circulating immune complexes in various forms of Behcet's disease. Int J Dermatol 1995;34:841-845.
55. Sticker H, Malinverni R: Multiple, large aneurysms of pulmonary arteries in Behcet's disease: clinical remission and radiologic resolution after corticosteroid therapy. Arch Intern Med 1989;149:925-927.
56. Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt GE, Yazici B, Somani S, Muftuoglu A: A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 1990;322:281-285.
57. Sfikakis PP: Behcet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002;61(suppl 2):ii51-ii53.
58. Nadrous HF, Yu AC, Specks U, Ryu JH: Pulmonary involvement in Henoch-Schonlein purpura. Mayo Clin Proc 2004;79:1151-1157.
59. Kathuria S, Cheifec G: Fatal pulmonary Henoch-Schonlein syndrome. Chest 1982;82:654-656.
60. Mollica F, Li Volti S, Garrozzo R, Russo G: Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992;151:140-144.
61. Pirot AL, Goldsmith D, Pascasio J, Beck SE: Pulmonary capillaritis with hemorrhage due to propylthiouracil therapy in a child. Pediatr Pulmonol 2005;39:88-92.
62. Dhillon SS, Singh D, Doe N, Qadri AM, Ricciardi S, Schwarz MI: Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest 1999;116:1485-1488.
63. Choi H, Merkel P, Walker A, Niles J: Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis. Arthritis Rheum 2000;43:405-413.
64. Nicolls MR, Terada LS, Tuder RM, Prindiville SA, Schwarz MI: Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med 1998;158:1302-1305.
65. Lin TS, Penza SL, Avalos BR, Lucarelli MR, Farag SS, Byrd JC, Copelan EA: Diffuse alveolar hemorrhage following gemtuzumab ozogamicin. Bone Marrow Transplant 2005;35:823-824.
66. Panagi S, Palka W, Korelitz BI, Taskin M, Lessnau KD: Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease. Inflamm Bowel Dis 2004;10:274-277.
67. Sansaoono D, Dammacco F: Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations. Lancet Infect Dis 2005;5: 227-236.
68. Bombardieri S, Paoletti P, Ferri C, Di Munno O, Fornal E, Giuntini C: Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979;66:748-756.
69. Gomez-Tello V, Onoro-Canaveral JJ, de la Casa Monje RM, Gomez-Casero RB, Moreno Hurtrez JL, Garcia-Montes M: Diffuse recidivant alveolar hemorrhage in a patient with hepatitis C virus-related mixed cryoglobulinemia. Intensive Care Med 1999;25:319-322.
70. Glassock RJ: Goodpasture's disease; in Massry SG, Glassock RJ (eds): Textbook of Nephrology. Baltimore, Williams & Wilkins, 2001, pp 808-813.
71. Hellmark T, Burkhardt H, Wieslander J: Goodpasture's disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 1999;274:25862-25868.
72. Rees AJ: Pulmonary injury caused by anti-basement membrane antibodies. Sem Resp Med 1984;5:264-272.
73. Simpson IJ, Doak PB, Williams LC, et al: Plasma exchange in Goodpasture's syndrome. Am J Nephrol 1982;2:301-311.
74. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM: Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J 1986;292:301-304.
75. Teague CA, Doak PB, Simpson IJ, Rainer SP, Herdson PB: Goodpasture's syndrome: an analysis of 29 cases. Kidney Int 1978;13:492-504.
76. Rees AJ, Peters DK, Compston DA, Batchelor JR: Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome. Lancet 1978;i:966-968.
77. Perl SI, Pussell BA, Charlesworth JA, Macdonald GJ, Wolnizer M: Goodpasture's (anti-GBM) disease and HLA-DRW2. N Engl J Med 1981;305:463-464.
78. Donaghy M, Rees AJ: Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983;ii:1390-1393.
79. Kelley PT, Haponik EF: Goodpasture's syndrome: molecular and clinical advances. Medicine (Baltimore) 1994;73:171-185.
80. Keogh AM, Ibels LS, Allen DH, Isbister JR, Kennedy MC: Exacerbation of Goodpasture's syndrome after inadvertent exposure to hydrocarbon fumes. Br Med J 1984;288:188.
81. Zimmerman SW, Varanasi UR, Hoff B: Goodpasture's syndrome with normal renal function. Am J Med 1979;76:163-171.
82. Wilson CB, Dixon FJ: Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 1973;3:74-89.
83. McCormack J, Kass J, Skewes M: Goodpasture's syndrome. Compr Ther 1987;13:25-32.
84. Levy JB, Turner AN, Rees AJ, Pusey CD: Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033-1042.
85. Hind CR, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ: Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet 1983;i:263-265.
86. Cohen S: Idiopathic pulmonary hemosiderosis. Am J Med Sci 1999;317:67-74.
87. Thaell JF, Greipp PR, Stubbs SE, Siegal GP: Idiopathic pulmonary hemosiderosis: two cases in a family. Mayo Clin Proc 1978;53: 113-118.
88. Bowley NB, Hughes JM, Steiner RE: The chest radiograph in pulmonary capillary haemorrhage: correlation with monoxide uptake. Clin Radiol 1979;30:413-417.
89. Wright PH, Buxton-Thomas M, Keeling PW, Kreel L: Adult idiopathic pulmonary haemosiderosis: a comparison of lung function changes and the distribution of pulmonary disease in patients with and without coeliac disease. Br J Dis Chest 1983;77:282-292.
90. Wright PH, Menzies IS, Punder RE, Keeling PW: Adult idiopathic pulmonary haemosiderosis and celiac disease. Q J Med 1981;50: 95-102.
91. Irwin RS, Cottrell TS, Hsu KC, Griswold WR, Thomas HM 3rd: Idiopathic pulmonary hemosiderosis: an electron microscopic and immunofluorescent study. Chest 1974;65:41-45.
92. Valassi-Adam H, Rouska A, Karpouzas J: Raised IgA in idiopathic pulmonary hemosiderosis. Arch Dis Child 1975;50:320-322.
93. Calabrese F, Giacometti C, Rea F, Loy M, Sartori F, Di Vittorio G, Abudureheman A, Thiene G, Valente M: Recurrence of idiopathic pulmonary hemosiderosis in a young adult after bilateral single-lung transplantation. Transplantation 2002;74:1643-1645.
94. Byrd RB, Gracey DR: Immunosuppressive treatment of idiopathic pulmonary hemosiderosis. JAMA 1973;226:458-459.
95. Pozo-Rodriguez F, Freire-Campo JM, Gutierrez- Millet V, Barbosa-Ayucar C, Diaz de Atauri J, Martin-Escribano P: Idiopathic pulmonary hemosiderosis treated by plasmapheresis. Thorax 1980;35:399-400.
96. Saeed MM, Woo MS, MacLaughlin EF, Margetis MF, Keens TG: Prognosis in pediatric idiopathic pulmonary hemosiderosis. Chest 1999;116:721-725.
97. Le Clainche L, Le Bourgeois M, Fauroux B, Forenza N, Dommergues JP, Desbois JC, Bellon G, Derelle J, Dutau G, Marguet C, Pin I, Tille-Leblond I, Scheinmann P, De Blic J: Long-term outcome of idiopathic pulmonary hemosiderosis in children. Medicine (Baltimore) 2000;79:318-326.
98. Albelda SM, Gefter WB, Epstein DM, Miller WT: Diffuse pulmonary hemorrhage: a review and classification. Radiology 1985;154:289-297.
99. Zeiss CR, Wolkonsky P, Chacon R, Tuntland PA, Levitz D, Prunzansky JJ, Patterson R: Syndromes in workers exposed to trimellitic anhydride. A longitudinal clinical and immunologic study. Ann Intern Med 1983;98:8-12.
100. Kaplan V, Baur X, Czuppon A, et al : Pulmonary hemorrhage due to inhalation of vapor containing pyromellitic dianhydride. Chest 1993;104:644-645.
101. Rivera M, Nicotra B, Byron GE, Ruegger M, Russi E, Speich R: Trimellitic anhydride toxicity: a cause of acute multisystem failure. Arch Intern Med 1981;141:1071-1074.
102. Patterson R, Nugent KM, Harris KE, Eberle ME: Immunologic hemorrhagic pneumonia caused by isocyanates. Am Rev Respir Dis 1990;141:226-230.
103. Herbert FA, Orford R: Pulmonary hemorrhage and edema due to inhalation of resins containing tri-mellitic anhydride. Chest 1979;76:546-551.
104. Ahmad D, Morgan WK, Patterson R, Williams T, Zeiss CR: Pulmonary haemorrhage and haemolytic anemia due to trimellitic anhydride. Lancet 1979;2:328-330.
105. Israel-Biet D, Labrune S, Huchon GJ: Drug-induced lung disease: 1990 review. Eur Respir J 1991;4:465-478.
106. Derk CT, Jimenez SA: Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature. J Rheumatol 2003;30:1616-1620.
107. Gavaghan TE, McNaught PJ, Ralston M, Hayes JM: Penicillamine-induced 'Goodpasture's syndrome': successful treatment of a fulminant case. Aust NZ Med 1981;11:261-265.
108. Louie S, Gamble CN, Cross CE: Penicillamine associated pulmonary hemorrhage. J Rheumatol 1986;13:963-966.
109. Swainson CP, Thomson D, Short AI, Winney RJ: Plasma exchange in the successful treatment of drug-induced renal disease. Nephron 1982;30:244-249.
110. Olson AL, Heard K: Class III antidysrhythmic agents; in Dart RC (ed): Medical Toxicology, ed 3. Philadelphia, Lippincott, Williams, & Wilkins, 2004, pp 689-699.
111. Vizioli LD, Cho S: Amiodarone-associated hemoptysis. Chest 1994;105:305-306.
112. Iskander S, Raible DG, Brozena SC, Gaitanaru DM, Ayala G, Isakndrian AE: Acute alveolar hemorrhage and orthodeoxia induced by intravenous amiodarone. Cathet Cardiovasc Interv 1999;47:61-63.
113. Goldstein I, Topilsky M, Segev D, Isakov A, Heller I: Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. Chest 1997;111:1446-1447.
114. Ravishankar R, Samuels LE, Kaufman MS, Samuels FL, Thomas MP, Galindo L, Morris RJ, Brockman SK: Amiodarone-associated hemoptysis. Am J Med Sci 1998;316:390-392.
115. Dean PJ, Groshart KD, Porterfield JG, Iansmith DH, Golden EB Jr: Amiodarone-associated pulmonary toxicity: a clinical and pathologic study of eleven cases. Am J Clin Pathol 1987;87:7-13.
116. Averbuch SD, Yungbluth P: Fatal pulmonary haemorrhage due to nitrofurantoin. Arch Intern Med 1980;140:271-273.
117. Bucknall CE, Adamson MR, Banham SW: Nonfatal pulmonary hemorrhage associated with nitrofurantoin. Thorax 1987;42:475-476.
118. Kalra S, Bell MR, Rihal CS: Alveolar hemorrhage as a complication of treatment with abciximab. Chest 2001;120:126-131.
119. Erdogan D, Kocaman O, Oflaz H, Goren T: Alveolar hemorrhage associated with warfarin therapy: a case report and literature review. Int J Cardiovasc Imag 2004;20:155-159.
120. Almagro P, Julia J, Sanjaume M, Gonzalez G, Casalots J, Heredia JL, Martinez J, Garau J: Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature. Medicine (Baltimore) 2002;81:417-424.
121. Faber CN, Yousem SA, Dauber JH, Griffith BP, Hardesty RL, Paradis IL: Pulmonary capillary hemangiomatosis: a report of three cases and a review of the literature. Am Rev Respir Dis 1989;140:808-813.
122. Langleben D, Heneghan JM, Batten AP, Wang NS, Fitch N, Schlesinger RD, Guerraty A, Rouleau JL: Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. Ann Intern Med 1988; 109:106-109.
123. de Perrot M, Waddell TK, Chamberlain D, Hutcheon M, Keshavjee S: De novo pulmonary capillary hemangiomatosis occurring rapidly after bilateral lung transplantation. J Heart Lung Transplant 2003;22:698-700.
124. Tron V, Magee F, Wright JL, Colby T, Churg A: Pulmonary capillary hemangiomatosis. Hum Pathol 1986;17:1144-1150.
125. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL: Treatment of pulmonary hemangiomatosis with recombinant interferon-alfa-2a. N Engl J Med 1989;320: 1197-1200.